Metropolis healthcare acquires Sanjivani Labs in an all-cash deal

Published On 2017-02-07 09:29 GMT   |   Update On 2017-02-07 09:29 GMT

Diagnostic company, Metropolis Healthcare has recently acquired Sanjivani Pathology Labs, Rajkot (Gujarat) in an all cash transaction. While the total amount has not been disclosed VC circle reports that this is an all-cash deal.


The aim of this takeover is to establish a stronger presence in western India, particularly the Gujrat market. Sanjeevani is reported to be Metropolis's largest laboratory acquisition in India to date, as confirmed by the statement of the company


Sanjeevani Pathology, which was founded in 1993, has four labs with a team of six senior pathologists, including founder and promoter Kirit Patel, in Rajkot, Gujarat.


To make its presence strong, Metropolis planning an expansion by either partnering or acquiring smaller brands in newer markets.


Metropolis, which started as a single lab in the 1980s, received its first external funding of Rs 35 crore from ICICI Venture in 2005. This was followed by a fresh funding of $85 million from private equity firm Warburg Pincus, giving an exit to ICICI Venture, reports VCCircle


Metropolis is backed by private equity fund KKR and a Carlyle Private Equity portfolio company.

 
Article Source : With inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News